CJC-1295 vs Sermorelin: Which GHRH Peptide Is Right for Your Research? (UAE 2026)
CJC-1295 vs Sermorelin: Which GHRH Peptide Is Right for Your Research? (UAE 2026)
Both CJC-1295 and Sermorelin are GHRH (Growth Hormone Releasing Hormone) analogues — peptides that stimulate the pituitary to secrete GH. Their fundamental difference is half-life: Sermorelin mimics natural GHRH's pulsatile pattern with a short half-life; CJC-1295 with DAC extends GH stimulation over days. This comparison explains which is appropriate for different research goals.
Head-to-Head Comparison
| Property | Sermorelin | CJC-1295 (no DAC) | CJC-1295 + DAC |
|---|---|---|---|
| Type | GHRH analogue (29 AA) | GHRH analogue (30 AA) | GHRH analogue + Drug Affinity Complex |
| Half-life | 10–20 minutes | 30 minutes | 6–8 days |
| GH pattern | Pulsatile (natural) | Pulsatile (slightly extended) | Sustained (blunted pulsatility) |
| IGF-1 elevation | Modest (+20–30%) | Moderate (+30–40%) | Significant (+200% at 2mg, 2× weekly) |
| Dosing | 100–300 mcg SC nightly | 100 mcg SC before sleep | 2mg SC 1–2× weekly |
| Most studied combination | Sermorelin + Ipamorelin | CJC-1295 + Ipamorelin/GHRP-6 | CJC-1295 DAC solo or + GHRP |
The DAC Difference Explained
The Drug Affinity Complex (DAC) on CJC-1295 + DAC is a chemical modification that causes the peptide to bind to serum albumin — dramatically extending its half-life from 30 minutes to 6–8 days. This creates sustained GH stimulation that is fundamentally different from pulsatile GHRH:
- CJC-1295 + DAC: Produces a GH "bleed" — sustained low-level elevation without discrete pulses. IGF-1 rises significantly. Some researchers consider the non-pulsatile pattern less physiologically optimal.
- CJC-1295 without DAC (MOD GRF 1-29): Short half-life creates a sharper GH pulse when combined with a GHRP — this is the preferred stack for research targeting natural GH pulsatility with enhanced amplitude.
Which Protocol for Which Research Goal?
CJC-1295 (no DAC) + Ipamorelin: The most popular research stack — CJC-1295 provides GHRH signal, Ipamorelin provides GHRP signal, together producing a robust GH pulse with minimal cortisol/prolactin side effects. Best for muscle recovery and body composition research.
CJC-1295 + DAC: Best for protocols requiring infrequent dosing (1–2× weekly) and sustained IGF-1 elevation. Research-efficient but non-pulsatile.
Related Products
Shop CJC-1295 & Sermorelin in Dubai
CJC-1295, Sermorelin, and Ipamorelin — individual and combination products available.
Shop CJC-1295FAQ
Yes — the CJC-1295 + Ipamorelin combination is one of the most researched peptide stacks. CJC-1295 (GHRH analogue) and Ipamorelin (GHRP/ghrelin mimetic) target two different receptors on the pituitary — when used together, they produce a synergistic GH pulse approximately 3–5× greater than either alone, with minimal cortisol or prolactin elevation compared to older GHRPs like GHRP-6.
Sermorelin has more established human clinical data — it was FDA-approved for paediatric GH deficiency and has been used in adult anti-aging medicine for over 20 years. CJC-1295 with DAC has published Phase I/II human data showing significant IGF-1 elevation. Both have a meaningful human research record.
CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.
Shop Bacteriostatic Water →Disclaimer: This article is for educational and research purposes only. All products mentioned are research compounds or investigational drugs not approved for general human therapeutic use in UAE. Consult a licensed UAE healthcare professional before beginning any protocol.
Written by Core Sup Research Team
Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE
Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.
Last reviewed: April 2026 · About Core Sup
